Introduction
Maple syrup urine disease (MSUD; types Ia MIM#248600, Ib MIM#248611 and II MIM# 248610), a metabolic disease that was first described by Menkes et al, 1 is an autosomal recessive inborn error disorder resulting from the defective activity of mitochondrial branched-chain a-ketoacid dehydrogenase (BCKAD), which catabolizes the oxidative decarboxylation of branched-chain a-ketoacids (BCKAs) from the branched-chain amino acids (BCAAs) leucine, isoleucine and valine. 2 Mutations in any of the E1a or E1b or DBT (dihydrolipoamide branched chain transacylase, E2) components of the BCKAD complex can result in classic, intermediate or intermittent MSUD. 3 Clinically, MSUD patients manifest with poor feeding, lethargy, seizures, developmental delay, psychomotor retardation, coma or death. Early diagnosis is essential to decrease morbidity and mortality. Molecular analysis of MSUD may be beneficial for early genetic counseling.
MSUD appears in all ethnic groups with a general incidence of less than 1 in 185 000 newborn infants in the general population. 2 Two founder mutations of MSUD in specific populations have been reported: An E1a Y393N mutation in the Old Order Mennonite population at a frequency of 1/176 4 and an E1b R183P mutation in Ashkenazi Jews at a frequency of 1/113. 5 Here, we report a novel E2 gene 4.7 kb founder deletion caused by an unusual nonhomologous recombination between the long interspersed nuclear elements 1(LINE-1) and Alu in three classic MSUD patients of the aboriginal tribe Paiwan. We also present the molecular characterization of the deletion breakpoints as well as the carrier frequency of this deletion in the tribe Paiwan, one of the nine Austronesian aboriginal tribes in Taiwan.
Materials and methods

Mutation analysis of the MSUD patients
Three unrelated classic form MSUD cases, one boy (patient 1) and two girls (patients 2 and 3), were documented in terms of clinical symptoms and abnormal elevation of plasma BCAAs. All patients belonged to the aboriginal tribe Paiwan of Taiwan. Genomic DNA was extracted from peripheral blood by the salting-out method. The intronic PCR primers were derived from Homo sapiens chromosome 19 working draft sequence segment (Gene Bank GI: 12741466) and Homo sapiens chromosome 6 working draft sequence segment (Gene Bank GI:12731894) to amplify all exons of E1a and E1b genes, respectively for sequence analysis (primer sequences are available by request). The E2 gene mutation analysis of genomic DNA was performed as previously described. 6 The amplicons were sequenced bidirectionally with the ABI PRIAM 3100 genetic analyzer (Applied Biosystems, Foster City, CA, USA). The primer set DelF (5 0 -TTCTGCAGGTCTGCTGGAGT-3 0 ) and DelB (5 0 -TGAGATGGCGTCTTGCTCTG-3 0 ) were used for amplification of the deleted allele. The PCR was annealed at 641C for 40 s and extended for 50 s at 721C.
Heterozygote detection of the E2 4.7 kb deletion and carrier-frequency determination in the Paiwan population The heterozygote of the E2 gene 4.7 kb deletion was detected with genomic DNA by duplex PCR with primers DelF, DelB, Ex11F (5 0 -CATTTCTAGGCCATTCCCCG-3 0 ) and Ex11B (5 0 -TGCTGGCACAGCTAGGGTTT-3 0 ), as previously described. The carrier-frequency study by duplex PCR was carried out with the approval of the Ethical Committee of the Taichung Veterans General Hospital. The geographic range included in our study was the mountainous area in Taitung County, one of the indigenous habitats of the tribe Paiwan in Southeastern Taiwan. A total of 242 blood samples were collected. The subjects of this study were unrelated individuals whose parents were both Paiwanese.
A total of 101 unrelated normal Paiwanese including 67 female and 34 male subjects were enrolled. Informed consent was obtained from all participants and all personal identifiers were stripped from the samples for the carrier analysis. although it was amplified successfully in patient 2 and normal controls. In attempting to achieve a successful exon 11 amplification, several genomic DNA PCR primer sets extending 2 kb beyond both coding region ends of exon 11 (Gene Bank GI: 22041703) were tried; however, negative PCR results were still obtained. We therefore postulated that there might be a homozygous deletion starting from somewhere around intron 10 of the E2 gene in patients 1 and 3.
Results
MSUD
Determination of the E2 4.7 kb deletion and the carrier study Primers DelF and DelB flanking the deletion junction were defined from patients 1 and 3 after several rounds of the PCR walking approach (data not shown). 0 UTR (data not shown). Duplex PCR was used to detect the heterozygous deletion status of the alleles. The primer set Ex11F -Ex11B served as the internal control to amplify exon 11 and DelF -DelB was used to amplify the deletion junction fragment. For normal alleles, the primer set Ex11F -Ex11B produces a 244-bp amplicon of exon 11, and Ex11F -DelB generates a 750-bp PCR fragment. The primer combinations of DelF -DelB and DelF -Ex11B were amplified unsuccessfully because of the nearly 5 kb distance between the forward and backward primers on the normal allele. For the deleted allele, a 388-bp fragment from the primer pair DelF -DelB was generated (Figure 2a) . Patients 1 and 3 generated only a 388-bp fragment from duplex PCR analysis, indicating that both of them were E2 gene 4.7 kb deletion homozygotes. Patient 2, an AT 2-bp deleted heterozygote, showed a heterozygous E2 gene 4.7 kb deletion (Figure 2b) .
The E2 4.7 kb deletion accounted for five out of six alleles in three Paiwanese MSUD patients revealing a founder effect of this deletion in the Paiwan population. Carrierfrequency study identified one E2 4.7 kb deleted heterozygote among 101 unrelated healthy aboriginal Paiwanese. 0 UTR. Duplex PCR with primer sets Ex11F -Ex11B and DelF -DelB were used to identify the heterozygous 4.7 kb deletion. Lys366 is the last residue encoded by exon 10. The residue number follows the numbering systems of Fisher et al. 7 (b) Gel image of the duplex PCR of the three MSUD patients. The 244-bp band was generated by Ex11F -Ex11B and the 750-bp fragment was generated by Ex11F -DelB in normal control (c). The 388-bp duplex PCR products produced by primer set DelF -DelB in patients 1 and 3 represent a homozygous E2 4.7 kb deletion (P1 and P3). The presence of all three bands in patient 2 (P2) represents a heterozygous deletion carrier. A 100-bp DNA ladder was used as a marker (M).
Characterization of the deletion
The sequences around the deletion junction showed two overlapped base pairs (gt) at the deletion junction ( Figure  1b,3 ) and no significant homology between this L1PA7 and Alu Sx, indicating a nonhomologous recombination event (Figure 3) . The recombination related elements appeared around the 5 0 or 3 0 breakpoints ( Figure 3 ) and are summarized in Table 1 .
Discussion
Several different types of small mutations have previously been reported in the E2 gene. 6,7,12 -14 However, large deletion of the E2 gene has only been reported once as a 15 -20 kb genomic DNA loss resulting from the recombination between an intronic Alu in intron 6 and the coding sequences of the terminal exon 11. 15 Here we report another large fragment deletion in the E2 gene. This E2 4.7 kb genomic DNA deletion may lead to failure to splice intron 10 or to alternative splicing of intron 10 with several possible cryptic splice acceptor sites in the nondeleted intron 10 or nondeleted 3 0 UTR according to the analysis with BDGP: Splice Site Prediction by Neural Network (http://www.fruitfly.org/seq_tools/splice.html) (data not shown). The mutated E2 protein may have amino acids replaced or deleted after Lys366 (Figure 2a) , thus it may lose the His391 active site 12 of the E2 catalytic domain resulting in the enzymatic inactivation of the E2 protein.
The changed or missing amino acids after Lys366 may also destroy the structure of the E2 catalytic domain and disrupt the assembly of intermediated active trimers that interlock through carboxyl-terminal hydrophobic knobs to produce the native 24-meric core, 14 thus affecting the assembly of the correct 24-mers cubic structure. Concerning the 3 0 UTR deletion, a major class of regulatory cis elements comprising adenosine -uridine pentamers (AUUUA) termed AU-rich elements (AREs) are repeated once or several times within the 3 0 UTR and are often found within U-rich regions of mRNA. AREs that function as RNA-destabilizing elements and target mRNA for rapid degradation in the cytoplasm have been found in numerous mRNA species. 16 The deleted 3 0 UTR region of the E2 4.7 kb deletion is a U-rich area containing one ARE pentamer (AUUUA) and one ARE hexamer (AUUUUA). The loss of these two AREs might produce a much more stable mutated E2 mRNA than normal E2 mRNA.
Alus and LINE-1 have been implicated in gene insertion and recombination, and accordingly are associated with several human diseases. 17 -19 Nonhomologous recombination between LINE-1 and Alu causing gene deletion, like the E2 4.7 kb deletion we report here, has only been reported once in the dystrophin gene 20 and has never been documented in the MSUD E2 or other genes. The L1PA7 in intron 10 of the E2 gene contains multiple small deletions, insertions and point mutations that leave the ORF1 and ORF2 of L1PA7 truncated (data not shown), indicating that the L1PA7 had lost its transposable activity, and it was thus probably not an active LINE-1. The 3 0 breakpoint of this 4.7 kb deletion was located on the right arm of the Alu Sx rather than the left arm, although the Alu recombination hotspots usually occur on the left arm due to the presence of the 26-bp core sequence. 21 There was a homologous Alu 26-bp core sequence (22/26) on the right arm of the Alu Sx in the recombining strand ( Figure 3 ). We therefore inferred that Alu might play a role in the E2 4.7 kb deletion. It is generally agreed that multiple mechanisms are involved in nonhomologous recombination. 19 Scaffold/ matrix-attached regions (S/MARs) may also be closely related to breakage events and gene recombination. 17, 19 We used MAR Finder (http://www.futuresoft.org/MAR-Wiz) to analyze the S/MARs potential with the 3 0 part of the E2 gene over a 12 kb region encompassing exon 10 to the end of the 3 0 UTR including the deletion region; however, no significant MAR potential was predicted at the 5 0 or 3 0 breakpoint sites (data not shown). The other specific elements including topoisomerase I and II recognition sites, chi-like sequences, direct repeats and inverted repeats that we characterized around the 5 0 and 3 0 breakpoints have also been implicated in gene recombination. 22 However, there is no evidence that these elements and sequence structures directly mediated this particular E2 nonhomologous recombination. We hypothesize that the possible cause of the Alu-LINE-1 associated nonhomologous recombination about this E2 4.7 kb deletion may be the 'homology-associated nonhomologous recombination'. 23 In Taiwan, fewer than 10 MSUD cases without accompanying gene analysis have been reported since 1986, 24, 25 although the incidence is much higher in the aboriginal tribes of Taiwan according to our data. The E2 4.7 kb deletion we describe here is not only the first MSUD genetic mutation identified in Taiwan but also a founder mutation in the Paiwan tribe. The aboriginal tribes of Taiwan, belonging to the Austronesian family, comprise 1.5% of the total population of Taiwan, and are divided into nine major groups including Amis, Puyuma, Yami, Atayal, Saisiyat, Bunun, Tsao, Rukai and Paiwan. As HLA class I genetic studies have shown, traits are highly homogenous within each tribe but different among tribes, and yet they have affinities to form a cluster together in the population dendrogram due to long-term isolation. 26 The tribes regionally distributed throughout the rugged internal mountains and along the eastern coast have individually distinct and sometimes mutually unintelligible languages and different material cultures and social organizations. They have common ancient origins that are temporally and geographically consistent with genetic, linguistic and archaeological studies. 27 In addition to the MSUD and the E2 4.7 kb deleted carriers identified in the tribe Paiwan, we also found the same E2 4.7 kb deletion in a carrier of the Puyuma tribe during the study period. This implies that this disease or deletion may also be preserved in some of the other Austronesian aboriginal tribes of Taiwan. We suggest that MSUD gene screening should be provided for the tribe Paiwan and the other Austronesian aboriginal tribes in Taiwan for the further investigation of the E2 gene 4.7 kb deletion status. We believe that this information may also be helpful for the study of MSUD among Austronesian families in other countries.
